SCHEMBL22911063

SCHEMBL22911063

COCCCN1CC(C(=O)N2CC3C(C2)[C@@H]2CN(C(=O)c4ccc5[nH]nnc5c4)C[C@H]32)Cc2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ PKM P14618 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CCNC P24863 2/20 0.33
▸ CDK8 P49336 2/20 0.33
▸ PYGL P06737 1/20 0.32
▸ PYGM P11217 1/20 0.32
▸ ROCK2 O75116 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16759902 1.00 KMT2A (0.37) KMT2AHSP90AA1HSP90AB1PKMCYP3A4
SCHEMBL22911059 0.91 KMT2A (0.34) KMT2AHSP90AA1HSP90AB1PKMCYP3A4
SCHEMBL22910767 0.77 IDH1 (0.41) ALDH1A1IDH1
SCHEMBL16759875 0.77 IDH1 (0.41) ALDH1A1IDH1
SCHEMBL16759849 0.77 PDK2 (0.33) PDK2IDH1
SCHEMBL22910833 0.77 PDK2 (0.33) PDK2IDH1
SCHEMBL22910820 0.77 KDM4E (0.36) HSP90AA1HSP90AB1ALDH1A1ROCK2PDK2
SCHEMBL18082352 0.77 KDM4E (0.36) HSP90AA1HSP90AB1ALDH1A1ROCK2PDK2
SCHEMBL16759906 0.71 TTK (0.36) KMT2ANPC1RAB9AMEN1L3MBTL1
SCHEMBL22911018 0.71 TTK (0.36) KMT2ANPC1RAB9AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2021-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL NPY1R, NPY2R, DECR1 KMT2A 2008/4885HSP90AA1 3756/4885HSP90AB1 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback